Literature DB >> 23561846

Hypomorphic mutations in PGAP2, encoding a GPI-anchor-remodeling protein, cause autosomal-recessive intellectual disability.

Lars Hansen1, Hasan Tawamie, Yoshiko Murakami, Yuan Mang, Shoaib ur Rehman, Rebecca Buchert, Stefanie Schaffer, Safia Muhammad, Mads Bak, Markus M Nöthen, Eric P Bennett, Yusuke Maeda, Michael Aigner, André Reis, Taroh Kinoshita, Niels Tommerup, Shahid Mahmood Baig, Rami Abou Jamra.   

Abstract

PGAP2 encodes a protein involved in remodeling the glycosylphosphatidylinositol (GPI) anchor in the Golgi apparatus. After synthesis in the endoplasmic reticulum (ER), GPI anchors are transferred to the proteins and are remodeled while transported through the Golgi to the cell membrane. Germline mutations in six genes (PIGA, PIGL, PIGM, PIGV, PIGN, and PIGO) in the ER-located part of the GPI-anchor-biosynthesis pathway have been reported, and all are associated with phenotypes extending from malformation and lethality to severe intellectual disability, epilepsy, minor dysmorphisms, and elevated alkaline phosphatase (ALP). We performed autozygosity mapping and ultra-deep sequencing followed by stringent filtering and identified two homozygous PGAP2 alterations, p.Tyr99Cys and p.Arg177Pro, in seven offspring with nonspecific autosomal-recessive intellectual disability from two consanguineous families. Rescue experiments with the altered proteins in PGAP2-deficient Chinese hamster ovary cell lines showed less expression of cell-surface GPI-anchored proteins DAF and CD59 than of the wild-type protein, substantiating the pathogenicity of the identified alterations. Furthermore, we observed a full rescue when we used strong promoters before the mutant cDNAs, suggesting a hypomorphic effect of the mutations. We report on alterations in the Golgi-located part of the GPI-anchor-biosynthesis pathway and extend the phenotypic spectrum of the GPI-anchor deficiencies to isolated intellectual disability with elevated ALP. GPI-anchor deficiencies can be interpreted within the concept of a disease family, and we propose that the severity of the phenotype is dependent on the location of the altered protein in the biosynthesis chain.
Copyright © 2013 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23561846      PMCID: PMC3617372          DOI: 10.1016/j.ajhg.2013.03.008

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

1.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.

Authors:  A Krogh; B Larsson; G von Heijne; E L Sonnhammer
Journal:  J Mol Biol       Date:  2001-01-19       Impact factor: 5.469

Review 2.  From syndrome families to functional genomics.

Authors:  Han G Brunner; Marc A van Driel
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

3.  MutationTaster evaluates disease-causing potential of sequence alterations.

Authors:  Jana Marie Schwarz; Christian Rödelsperger; Markus Schuelke; Dominik Seelow
Journal:  Nat Methods       Date:  2010-08       Impact factor: 28.547

4.  Multiple congenital anomalies-hypotonia-seizures syndrome is caused by a mutation in PIGN.

Authors:  Gal Maydan; Iris Noyman; Adi Har-Zahav; Ziva Ben Neriah; Metsada Pasmanik-Chor; Adva Yeheskel; Adi Albin-Kaplanski; Idit Maya; Nurit Magal; Efrat Birk; Amos J Simon; Ayelet Halevy; Gideon Rechavi; Mordechai Shohat; Rachel Straussberg; Lina Basel-Vanagaite
Journal:  J Med Genet       Date:  2011-04-14       Impact factor: 6.318

5.  Developmental abnormalities of glycosylphosphatidylinositol-anchor-deficient embryos revealed by Cre/loxP system.

Authors:  M Nozaki; K Ohishi; N Yamada; T Kinoshita; A Nagy; J Takeda
Journal:  Lab Invest       Date:  1999-03       Impact factor: 5.662

6.  Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency.

Authors:  Antonio M Almeida; Yoshiko Murakami; D Mark Layton; Peter Hillmen; Gabrielle S Sellick; Yusuke Maeda; Stephen Richards; Scott Patterson; Ioannis Kotsianidis; Luigina Mollica; Dorothy H Crawford; Alastair Baker; Michael Ferguson; Irene Roberts; Richard Houlston; Taroh Kinoshita; Anastasios Karadimitris
Journal:  Nat Med       Date:  2006-06-11       Impact factor: 53.440

7.  PGAP2 is essential for correct processing and stable expression of GPI-anchored proteins.

Authors:  Yuko Tashima; Ryo Taguchi; Chie Murata; Hisashi Ashida; Taroh Kinoshita; Yusuke Maeda
Journal:  Mol Biol Cell       Date:  2006-01-11       Impact factor: 4.138

8.  Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome.

Authors:  Peter M Krawitz; Michal R Schweiger; Christian Rödelsperger; Carlo Marcelis; Uwe Kölsch; Christian Meisel; Friederike Stephani; Taroh Kinoshita; Yoshiko Murakami; Sebastian Bauer; Melanie Isau; Axel Fischer; Andreas Dahl; Martin Kerick; Jochen Hecht; Sebastian Köhler; Marten Jäger; Johannes Grünhagen; Birgit Jonske de Condor; Sandra Doelken; Han G Brunner; Peter Meinecke; Eberhard Passarge; Miles D Thompson; David E Cole; Denise Horn; Tony Roscioli; Stefan Mundlos; Peter N Robinson
Journal:  Nat Genet       Date:  2010-08-29       Impact factor: 38.330

9.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

Review 10.  Biosynthesis, remodelling and functions of mammalian GPI-anchored proteins: recent progress.

Authors:  Taroh Kinoshita; Morihisa Fujita; Yusuke Maeda
Journal:  J Biochem       Date:  2008-07-17       Impact factor: 3.387

View more
  43 in total

1.  MAN1B1 Mutation Leads to a Recognizable Phenotype: A Case Report and Future Prospects.

Authors:  Sabine Hoffjan; Jörg T Epplen; André Reis; Rami Abou Jamra
Journal:  Mol Syndromol       Date:  2015-03-04

2.  Delineation of PIGV mutation spectrum and associated phenotypes in hyperphosphatasia with mental retardation syndrome.

Authors:  Denise Horn; Dagmar Wieczorek; Kay Metcalfe; Ivo Barić; Lidija Paležac; Mario Cuk; Danijela Petković Ramadža; Ulrike Krüger; Stephanie Demuth; Wolfram Heinritz; Tobias Linden; Jens Koenig; Peter N Robinson; Peter Krawitz
Journal:  Eur J Hum Genet       Date:  2013-10-16       Impact factor: 4.246

Review 3.  Congenital disorders of glycosylation.

Authors:  Irene J Chang; Miao He; Christina T Lam
Journal:  Ann Transl Med       Date:  2018-12

Review 4.  Solving glycosylation disorders: fundamental approaches reveal complicated pathways.

Authors:  Hudson H Freeze; Jessica X Chong; Michael J Bamshad; Bobby G Ng
Journal:  Am J Hum Genet       Date:  2014-02-06       Impact factor: 11.025

5.  Mutations in PIGS, Encoding a GPI Transamidase, Cause a Neurological Syndrome Ranging from Fetal Akinesia to Epileptic Encephalopathy.

Authors:  Thi Tuyet Mai Nguyen; Yoshiko Murakami; Kristen M Wigby; Nissan V Baratang; Justine Rousseau; Anik St-Denis; Jill A Rosenfeld; Stephanie C Laniewski; Julie Jones; Alejandro D Iglesias; Marilyn C Jones; Diane Masser-Frye; Angela E Scheuerle; Denise L Perry; Ryan J Taft; Françoise Le Deist; Miles Thompson; Taroh Kinoshita; Philippe M Campeau
Journal:  Am J Hum Genet       Date:  2018-09-27       Impact factor: 11.025

6.  Expanding the clinical and mutational spectrum of Kaufman oculocerebrofacial syndrome with biallelic UBE3B mutations.

Authors:  Lina Basel-Vanagaite; Rüstem Yilmaz; Sha Tang; Miriam S Reuter; Nils Rahner; Dorothy K Grange; Megan Mortenson; Patrick Koty; Heather Feenstra; Kelly D Farwell Gonzalez; Heinrich Sticht; Nathalie Boddaert; Julie Désir; Kwame Anyane-Yeboa; Christiane Zweier; André Reis; Christian Kubisch; Tamison Jewett; Wenqi Zeng; Guntram Borck
Journal:  Hum Genet       Date:  2014-03-11       Impact factor: 4.132

7.  Novel compound heterozygous PIGT mutations caused multiple congenital anomalies-hypotonia-seizures syndrome 3.

Authors:  Mitsuko Nakashima; Hirofumi Kashii; Yoshiko Murakami; Mitsuhiro Kato; Yoshinori Tsurusaki; Noriko Miyake; Masaya Kubota; Taroh Kinoshita; Hirotomo Saitsu; Naomichi Matsumoto
Journal:  Neurogenetics       Date:  2014-06-08       Impact factor: 2.660

8.  Mutations in PGAP3 impair GPI-anchor maturation, causing a subtype of hyperphosphatasia with mental retardation.

Authors:  Malcolm F Howard; Yoshiko Murakami; Alistair T Pagnamenta; Cornelia Daumer-Haas; Björn Fischer; Jochen Hecht; David A Keays; Samantha J L Knight; Uwe Kölsch; Ulrike Krüger; Steffen Leiz; Yusuke Maeda; Daphne Mitchell; Stefan Mundlos; John A Phillips; Peter N Robinson; Usha Kini; Jenny C Taylor; Denise Horn; Taroh Kinoshita; Peter M Krawitz
Journal:  Am J Hum Genet       Date:  2014-01-16       Impact factor: 11.025

9.  A homozygous PIGO mutation associated with severe infantile epileptic encephalopathy and corpus callosum hypoplasia, but normal alkaline phosphatase levels.

Authors:  Yoav Zehavi; Anja von Renesse; Etty Daniel-Spiegel; Yonatan Sapir; Luci Zalman; Ilana Chervinsky; Markus Schuelke; Rachel Straussberg; Ronen Spiegel
Journal:  Metab Brain Dis       Date:  2017-09-13       Impact factor: 3.584

10.  Pathogenic Variants in PIGG Cause Intellectual Disability with Seizures and Hypotonia.

Authors:  Periklis Makrythanasis; Mitsuhiro Kato; Maha S Zaki; Hirotomo Saitsu; Kazuyuki Nakamura; Federico A Santoni; Satoko Miyatake; Mitsuko Nakashima; Mahmoud Y Issa; Michel Guipponi; Audrey Letourneau; Clare V Logan; Nicola Roberts; David A Parry; Colin A Johnson; Naomichi Matsumoto; Hanan Hamamy; Eamonn Sheridan; Taroh Kinoshita; Stylianos E Antonarakis; Yoshiko Murakami
Journal:  Am J Hum Genet       Date:  2016-03-17       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.